The epidemiology of thyroid cancer in the Czech Republic in comparison with other countries

Biomedical Papers

Volumn 157, Issue 3, 2013, Pages 266-275

  Lukas, Jindrich ^a   Drabek, Jiri ^b   Lukas, David ^a   Dusek, Ladislav ^c   Gatek, Jiri ^d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

^d Atlas Hospital   (Czech Republic)

Author keywords

Carcinoma of thyroid gland; Epidemiology; Risk factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CZECH REPUBLIC; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RADIATION INJURY; SEX RATIO; THYROID TUMOR; TUMOR VOLUME;

ADULT; AGE DISTRIBUTION; AGED; CZECH REPUBLIC; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MORTALITY; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIATION INJURIES; SEX DISTRIBUTION; THYROID NEOPLASMS; TUMOR BURDEN;

EID: 84887291134     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2012.086     Document Type: Article

References (42)

1. Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 2010;22:395-404.
2. Becker HD, Hohenberger W, Junginger T, Schlag PM. Chirurgicka onkologie. 1 ed. Prague Grada Publishing, a.s., 2005.
3. Vlcek P. Tumours thyroid gland. Postgradualni medicina 2007;9:190-194.
4. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyreoid cancer: A review of epidemiology, pathogenesis and treatment. J of Oncology 2011;2011:542358.
5. Pederesen RK, Pederesen NT. Primary non-Hodgin's lymphoma of the thyroid gland: a population based study. Histopathology 1996;28:25-32.
6. Cap J, Ryska A. Fine-needle aspiration biopsy of the thyroid gland. Hradec Kralove: Nucelus HK, 2003;178 s.
7. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A. International patterns and trends in thyroid cancer incidence, 19732002. Cancer Causes Control 2009;20:525-531.
8. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. Jama 2006;295:2164-2167.
9. Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devessa S. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 2011;21:125-134.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide. IARC Cancer Base No. 10. Lyon: IARC 2010. [cited 2010 Sep 22]. Available from: http://globocan.iarc.fr.
11. Dvorak J. Thyroid carcinoma. Praha: Libri; 1997, 303 s.
12. Limanova Z. Thyroid carcinoma-diagnosis and treatment. Intern f medicina pro praxi 2003;6:308-314.
13. Pacesova P. Thyroid cancer and malignant lymphoma-is there relationship? Prakticky lekar 2007;87:178-181.
14. Dusek L, Muzik J, Kubasek M, Koptikova J, Zaloudik J, Vyzula R. Epidemiology of malignant tumours in the Czech Republik [online]. Masaryk University 2005 [cited 2008 Dec 15]. Available from: http://www.svod.cz.
15. Fagin JA, Mitsiades N. Molecular patology of thyroid cancer: diagnostic and clinical implications. Best Pract & Res Clin Endocrinol&Metab 2008;22(6):955-969.
16. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006;7:21-33.
17. Nekulova M, Simickova M, Valik O. Tumor markers and epigenetic factors. Klinicka biochemie a metabolismus 2006;14:152-156.
18. Powell JG, Hay ID. Papillary carcinoma of the thyroid. In: Randolph GW, editor. Surgery of the thyroid and parathyroid glanc. Philadelphia: Elsevier Science;2003, p.188-209.
19. Cardis E, Hatch M. The Chernobyl accident-an epidemiological perspective. Clin Oncol (R Coll Radiol) 2011;23:251-260.
20. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature 1992;359:21-23.
21. Likhatov I, Kovgan L, Vavilov S, Chepurny M, Bouville A, Luckyanov N, Jacob P, Voillequ AP, Voigt G. Post-Chernobyl thyroid cancers in Ukraine. Report 1: estimation of thyroid doses. Radiat Res 2005;163:125-136.
22. Williams ED, Pacini F, Pinchera A. Thyroid cancer following Chernobyl. J Endocrinol Invest 1995;18:144-146.
23. Kolektiv autoru. Patnact let od havarie Cernobylu-dusledky a pouceni. Praha: SUJB, 2001; http://www.subj.cz
24. Wartofsky L. Increasing world incidence of thyroid cancer. Increased detection or higher radiation exposure? Hormones 2010;9(2):103-108.
25. Pellegriti G, De VF, Scollo C, Attard M, Giordano C, Arena S, Dardanoni G, Vigneri R. Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst 2009;101:1575-1583.
26. Ward MH, Kilfoy BA, Weyer PJ, Anderson KE, Folsom AR, Cerhan JR. Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 2010;21:389-395.
27. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 2005;365:2014-2023.
28. Yang GC, LiVolsi VA, Baloch ZW. Thyroid microcarcinoma: fine-nee-dle aspiration diagnosis and histologic follow-up. Int J Surg Pathol 2002;10:133-139.
29. Nemec J, Chytry P, Dvorak J, Vlcek P, Neradilova M, Racek P, Blazek T, Zeman V. Effect of sex on the prevalence and survival in thyroid carcinoma.Vnitr lek 1996;42:602-604.
30. Mazzaferri EL. Management of low-risk differentiated thyroid cancer. Endocr Pract 2007;13:498-512.
31. Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996;3:534-538.
32. Bhattacharyya N. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg 2003;128:115-123.
33. Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radial neck dissection. World J Surg 2007;31:2085-2091.
34. Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 2005;71:731-734.
35. Lee SH, Lee SS, Jin SM, Kim JH, Rho YS. Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma. Laryngoscope 2008;118:659-662.
36. Lee J, Soh EY. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis: clinical outcome and prognostic factors. Ann Surg 2010;251:114-119.
37. Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo R. BRAF (V E) station and outcome of patiens with papillary thyroid carcinoma: 15-year median follow-up study. J Clin Endocrinol Metab 2008;93:3943-3949.
38. Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G. Association of BRAF V600E mutation with poor clinicopathologi-cal outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 2007;92:4085-4090.
39. Brzezianska E, Pastuszak-Lewandoska D, Wojciechowska K, Migdalska-Sek M, Cyniak-Magierska A, Nawrot E, Lewinski A. Investigation of V600E BRAF station in papillary thyroid carcinoma in the Polish population. NeuroEndocrinol Lett 2007;28:351-353.
40. Kumar A, Bal CS. Differentiated thyroid cancer. Indian J Pediatr 2003; 70:707-713.
41. Elaraj DM, Clark OH. Changing management in patiens with papillary toroid cancer. Curr Treat Options Oncol 2007; 8(4):305-313.
42. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon A. Extent of Sumery affects survival for papillary thyroid cancer. Ann Surg 2007; 246:375-381.